Sanofi Is in No Rush to Reach Deal With Genzyme

Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree o…

Genzyme Sells Genetic Testing Unit to LabCorp for $925 Million

Genzyme (GENZ) announced that it has agreed to sell Genzyme Genetics to Laboratory Corporation of America Holdings (LabCorp) (LH) for for $925 million in cash.

Cambridge, Mass.-based Genzyme said that under the terms of the agreement, LabCorp will pur…

Genzyme Sells Genetic Testing Unit to LabCorp for $925 Million

Genzyme (GENZ) announced that it has agreed to sell Genzyme Genetics to Laboratory Corporation of America Holdings (LabCorp) (LH) for for $925 million in cash.

Cambridge, Mass.-based Genzyme said that under the terms of the agreement, LabCorp will pur…

Worst August Since 2006 for U.S. Video Game Sales

Last month was the worst August in four years for U.S. video game sales, according to a new NPD Group report. Revenue fell 10% from August of last year as gamers scaled back on portable-gaming purchases and turned to — often f…